( March 5, 2026, 10:47 AM EST) -- ATLANTA — Teva Pharmaceuticals USA Inc. renewed its motion to certify an order for interlocutory appeal to the 11th Circuit U.S. Court of Appeals of a ruling in the Paragard intrauterine device (IUD) multidistrict litigation that information can retroactively apply as newly acquired information under the U.S. Food and Drug Administration’s changes-being-effected (CBE) regulation....